UK diagnostics ready to meet multiple challenges
This article was originally published in Clinica
The British In Vitro Diagnostics Association (BIVDA) is ready to spearhead a promotional campaign that effectively consolidates the sector's efforts to meet a two-pronged attack from healthcare reforms and growing pressures to tighten performance against a solid increase in demand.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.